Helix BioPharma Corp. (HBPCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 11:34AM EDT
| Previous Close | 0.1377 |
| Open | 0.1378 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1377 - 0.1377 |
| 52 Week Range | 0.1377 - 0.1500 |
| Volume | |
| Avg. Volume | 498 |
| Market Cap | 33.348M |
| Beta (5Y Monthly) | -0.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Apr 16, 2024 - Apr 21, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- News Direct
Helix BioPharma Corp. Reports Voting Results
January 18, 2024 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field o...
News DirectHelix BioPharma Corp. Announces Fiscal 2024 First Quarter Results
Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field...
- Baystreet
Stocks in play: Helix BioPharma Corp.
Will present new preclinical data on L-DOS47 in combination with PD1 checkpoint inhibition at the 2023 ...
© 2024 Yahoo. All rights reserved.